Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0064 | 0.9706 | 0.9706 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0055 | 0.726 | 0.6319 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0063 | 0.9243 | 1 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0039 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0065 | 1 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0063 | 0.9243 | 0.5489 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0065 | 1 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0063 | 0.9243 | 1 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0059 | 0.8321 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0065 | 1 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0063 | 0.9243 | 0.5489 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0064 | 0.9706 | 0.9706 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0065 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0039 | 0.2852 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0064 | 0.9706 | 0.9706 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0063 | 0.9243 | 0.5489 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0039 | 0.2852 | 0.5 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0059 | 0.8321 | 0.8558 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0063 | 0.9243 | 0.5489 |
Onchocerca volvulus | 0.0065 | 1 | 0.5 | |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0063 | 0.9243 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0064 | 0.9706 | 0.9706 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0065 | 1 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0063 | 0.9243 | 0.9243 |
Loa Loa (eye worm) | hypothetical protein | 0.0064 | 0.9706 | 0.9604 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0065 | 1 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0059 | 0.8321 | 0.8558 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0063 | 0.9243 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0063 | 0.9243 | 1 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0059 | 0.8321 | 0.8321 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (ADMET) | = 110.3 uM | Cytotoxicity against human U937 cells | ChEMBL. | 20035557 |
Inhibition (binding) | Inhibition of Mycobacterium tuberculosis mycothiol disulfide reductase assessed as NADPH oxidation at 800 uM by Ellmans reagent method | ChEMBL. | 20035557 | |
Inhibition (functional) | = 99.5 % | Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in human U937 cells at MBC by radiometric method | ChEMBL. | 20035557 |
MBC (functional) | = 735.1 uM | Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in human U937 cells by radiometric method | ChEMBL. | 20035557 |
MIC (functional) | = 367.6 uM | Antitubercular activity against Mycobacterium tuberculosis H37Rv by radiometric method | ChEMBL. | 20035557 |
MIC (functional) | = 367.6 uM | Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in human U937 cells by radiometric method | ChEMBL. | 20035557 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.